CompletedPhase 3NCT02408484
Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency
Studying Congenital fibrinogen deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Octapharma
- Principal Investigator
- Cristina Solomon, MDOctapharma
- Intervention
- Octafibrin(biological)
- Enrollment
- 15 enrolled
- Eligibility
- 11 years · All sexes
- Timeline
- 2015 – 2019
Study locations (4)
- St. John's Medical College Hospital, Bangalore, India
- S.S Institute of Medical Science and Research Center, Davangere, India
- Nemazee Hospital Shiraz University of Medical Sciences, Shiraz, Iran
- Hotel De Dieu de France, Beirut, Lebanon
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02408484 on ClinicalTrials.govOther trials for Congenital fibrinogen deficiency
Additional recruiting or active studies for the same condition.